XURIDEN is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Wellstat Therapeutics Corporation. The primary component is Uridine Triacetate.
Product ID | 69468-152_295791f6-d738-4498-9033-e749be179c88 |
NDC | 69468-152 |
Product Type | Human Prescription Drug |
Proprietary Name | XURIDEN |
Generic Name | Uridine Triacetate |
Dosage Form | Granule |
Route of Administration | ORAL |
Marketing Start Date | 2015-09-08 |
Marketing Category | NDA / NDA |
Application Number | NDA208169 |
Labeler Name | Wellstat Therapeutics Corporation |
Substance Name | URIDINE TRIACETATE |
Active Ingredient Strength | 951 mg/g |
Pharm Classes | Pyrimidine Analog [EPC],Pyrimidines [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-09-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208169 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-09-08 |
Marketing Category | NDA |
Application Number | NDA208169 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-09-08 |
Ingredient | Strength |
---|---|
URIDINE TRIACETATE | 951 mg/g |
SPL SET ID: | 40606ca9-4f14-45b7-8632-fc2d17d11a2e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
69468-152 | XURIDEN | uridine triacetate |
69468-151 | VISTOGARD | uridine triacetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XURIDEN 85386985 4822320 Live/Registered |
Wellstat Therapeutics Corporation 2011-08-02 |